
New Pancreatic Cancer Drug Doubles Survival Time in Trial
A breakthrough pill for pancreatic cancer almost doubled survival time and cut death risk by 60% in a major trial. Revolution Medicines plans to seek fast-track FDA approval for patients who desperately need new treatment options.






-growing-in-single-files-along-collagen-fibres-(red)_renee-flaherty.jpg%3Fsfvrsn%3Db3bf3bc8_1)


